Companies typically share these documents after their studies are
complete. The disclosures while the trials are still underway, a rare
move, are aimed at addressing growing suspicion among Americans that
President Donald Trump's drive to produce a vaccine before the
election on Nov. 3 could result in a product that was unsafe.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/moderna-pfizer-blueprints-revealed-vaccine-frontrunners-bow-to-public-pressure-abandon-secrecy/articleshow/78182009.cms
No comments:
Post a Comment